AbbVie's change in receivables for the quarter that ended in Dec. 2023 was USD339 Mil. It means AbbVie's Accounts Receivable
declined by USD339 Mil
from Sep. 2023 to Dec. 2023 .
AbbVie's change in receivables for the fiscal year that ended in Dec. 2023 was USD66 Mil. It means AbbVie's Accounts Receivable
declined by USD66 Mil
from Dec. 2022 to Dec. 2023 .
AbbVie's Accounts Receivable for the quarter that ended in Dec. 2023 was USD11,155 Mil.
Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
AbbVie's Days Sales Outstanding for the
three
months ended in Dec. 2023 was 71.18.
In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. AbbVie's liquidation value for the
three
months ended in Dec. 2023 was USD-101,082 Mil.
AbbVie Change In Receivables Historical Data
The historical data trend for AbbVie's Change In Receivables can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.
Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was USD66 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AbbVie (NYSE:ABBV) Change In Receivables Explanation
1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
AbbVie's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AbbVie Change In Receivables Related Terms
Thank you for viewing the detailed overview of AbbVie's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.
AbbVie is a pharmaceutical firm with a strong exposure to immunology and oncology. The firm's top drug, Humira, represents close to half of the company's current profits. The company was spun off from Abbott in early 2013. The recent acquisition of Allergan adds several new drugs in aesthetics and women's health.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ABBV has been successfully added to your 